Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2025-12-25 @ 7:10 PM
Study NCT ID:
NCT04348032
Status:
UNKNOWN
Last Update Posted:
2022-03-31
First Post:
2020-04-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Apatinib Combined With PLD vs PLD for Platinum-resistant Recurrent Ovarian Cancer
Sponsor:
Chinese Academy of Medical Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-22
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-04-14
First Submit QC Date:
None
Study First Post Date:
2020-04-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-28
Last Update Post Date:
2022-03-31
Last Update Post Date Type:
ACTUAL